drugset / Trial / NCT01302028

Renal Impairment Study With ASP1941

NCT01302028

Phase 1 Completed 40 enrolled Astellas Pharma Inc
RandomizedParallel-groupOpen-labelBasic science

Summary

A study to investigate if the pharmacokinetics of ASP1941 is different in Type 2 Diabetes Mellitus (T2DM) patients with different grades of renal failure compared with T2DM patients with normal renal function and healthy volunteers.

Timeline

Start
2010-01-22
Primary completion
2010-06-26
Completion
2010-06-26

Drugs

EvaluationDrugModalityDoseRoute
Subject ipragliflozin Small molecule Oral